학술논문
Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study
Document Type
Article
Author
Source
In Digestive and Liver Disease August 2024 56(8):1312-1318
Subject
Language
ISSN
1590-8658